SCHEMBL3067435

SCHEMBL3067435

CC/C=C/C/C=C/C/C=C/C/C=C/C/C=C/C/C=C/CC(C)(C)C(=O)OC(CO)CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
CNR1 P21554 3/20 0.41
MAPT P10636 2/20 0.41
CNR2 P34972 2/20 0.41
FAAH O00519 1/20 0.41
HPGD P15428 1/20 0.41
PRKCA P17252 1/20 0.39
CYP19A1 P11511 2/20 0.35
RXRA P19793 2/20 0.35
PPARG P37231 2/20 0.35
OXER1 Q8TDS5 2/20 0.35
FFAR1 O14842 1/20 0.35
PTGS1 P23219 2/20 0.33
ADORA3 P0DMS8 2/20 0.33
NR1I2 O75469 1/20 0.33
PGR P06401 1/20 0.33
PTGS2 P35354 1/20 0.33
PDE4D Q08499 1/20 0.33
F7 P08709 1/20 0.33
F3 P13726 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3067437 1.00 ALDH1A1 (0.41) ALDH1A1CNR1MAPTCNR2FAAH
SCHEMBL444329 0.77 ADORA3 (0.47) ALDH1A1CNR1MAPTCNR2HPGD
SCHEMBL2882121 0.72 ALDH1A1 (0.48) ALDH1A1CNR1MAPTCNR2FAAH
SCHEMBL29358627 0.71 ALDH1A1 (0.66) ALDH1A1CNR1MAPTCNR2FAAH
SCHEMBL26431688 0.71 PRKCA (0.47) ALDH1A1CNR1MAPTCNR2FAAH
SCHEMBL3066157 0.70 ALDH1A1 (0.42) ALDH1A1CNR1MAPTCNR2FAAH
SCHEMBL3066159 0.70 ALDH1A1 (0.42) ALDH1A1CNR1MAPTCNR2FAAH
SCHEMBL3068618 0.69 ALDH1A1 (0.41) ALDH1A1CNR1MAPTCNR2FAAH
SCHEMBL13084156 0.69 ALDH1A1 (0.81) ALDH1A1CNR1MAPTCNR2FAAH
SCHEMBL3068622 0.69 ALDH1A1 (0.41) ALDH1A1CNR1MAPTCNR2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267828-A1 DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS PRONOVA BIOPHARMA NORGE AS (NO) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267828-A1 DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS LIPA, LPL, PNLIP ALDH1A1 1114/4885CNR1 584/4885MAPT 4554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.